0000950170-24-074365.txt : 20240617
0000950170-24-074365.hdr.sgml : 20240617
20240617170705
ACCESSION NUMBER: 0000950170-24-074365
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240614
FILED AS OF DATE: 20240617
DATE AS OF CHANGE: 20240617
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Giles Lisa M.
CENTRAL INDEX KEY: 0001568850
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40591
FILM NUMBER: 241049177
MAIL ADDRESS:
STREET 1: DURATA THERAPEUTICS, INC.
STREET 2: 200 SOUTH WACKER DRIVE SUITE 2550
CITY: CHICAGO
STATE: IL
ZIP: 60606
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HCW Biologics Inc.
CENTRAL INDEX KEY: 0001828673
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 825024477
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2929 N COMMERCE PKWY
CITY: MIRAMAR
STATE: FL
ZIP: 33025
BUSINESS PHONE: 954-842-2024
MAIL ADDRESS:
STREET 1: 2929 N COMMERCE PKWY
CITY: MIRAMAR
STATE: FL
ZIP: 33025
4
1
ownership.xml
4
X0508
4
2024-06-14
false
0001828673
HCW Biologics Inc.
HCWB
0001568850
Giles Lisa M.
C/O HCW BIOLOGICS INC
2929 N. COMMERCE PARKWAY
MIRAMAR
FL
33025
true
false
false
false
false
Stock Option (Right to Buy)
1.12
2024-06-14
4
A
false
12500
0
A
2025-06-13
Common Stock
12500
12500
D
(1) 100% of the total number of shares subject to the Option shall vest and become exercisable on the earlier of (a) June 13, 2025 or (b) the next annual meeting of stockholders, subject to the Reporting Person continuing to provide services through the vesting date.
/s/ Nicole Valdivieso, as Attorney-in-Fact for Lisa M. Giles
2024-06-17